SCs can be activated by tumour-secreted proteins, e.g., TNFα, which is characterized by the upregulation of activation markers (e.g., c-Jun, glial fibrillary acidic protein, and p75NTR) and the cascade expression of NGF and TNFα (Salvo et al. 2021). This evidence concerns the gene NGFR and neoplasm.